Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. ANGO
ANGO logo

ANGO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ANGO News

Bastion Asset Management Acquires Stake in Parsons

Feb 27 2026Fool

Bastion Asset Management Acquires $8M Stake in Parsons

Feb 27 2026Yahoo Finance

AngioDynamics to Present at Global Healthcare Conference

Feb 23 2026Newsfilter

NanoKnife Technology Expands European Indications for Tumor Treatment

Feb 19 2026Newsfilter

AngioDynamics (ANGO) Q3 2025 Earnings Transcript

Jan 06 2026NASDAQ.COM

AngioDynamics (ANGO) Q1 2026 Earnings Transcript

Jan 06 2026NASDAQ.COM

AngioDynamics (ANGO) Q2 2026 Earnings Transcript

Jan 06 2026NASDAQ.COM

AngioDynamics (ANGO) Q1 2025 Earnings Transcript

Jan 06 2026NASDAQ.COM

Alumis Inc. Shares Surge 132% After Successful Phase 3 Trial Results

Jan 06 2026Benzinga

AngioDynamics Reports 8.8% Revenue Growth in Q3 but Shares Plunge 13.1%

Jan 06 2026Fool

AngioDynamics Surpasses Expectations with $79.4M Sales and Break-Even EPS

Jan 06 2026Benzinga

AngioDynamics Maintains 2026 Adjusted Loss Guidance, Raises Sales Outlook to $312M-$314M

Jan 06 2026NASDAQ.COM

AngioDynamics Reports 8.8% Net Sales Growth to $79.4 Million in Q2

Jan 06 2026Newsfilter

Microchip Technology Raises Q3 FY2026 Sales Guidance to $1.185 Billion

Jan 06 2026Benzinga

Dow Jones Hits All-Time High as Market Sentiment Improves

Jan 06 2026Benzinga

AngioDynamics to Report Q2 FY26 Earnings with Expected Loss of $0.10 per Share

Dec 30 2025Benzinga